Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by princeofcuton Sep 10, 2015 4:15pm

78 Views

Post# 24093966

RE:bias, censorship and the scam MB...

and boys and girls it gets even funnier regarding bias and censorship...it seems good old chicago is a CPA so like me he actually knows how and likely reads all RVX formal filings, which makes him likely 100% more qualified to speak to most things RVX than the other posters over there...and because he is more knowing and posts with that knowing gets attacked because the pumpertrasholes and rubes just hate his message...too funny and BTW the scam has a sordid and continuous history of censorship

..and bearskinned just for you i expect RVX to have higher price by the AGM

Bullboard Posts

Eminent acquires promising Nevada gold project